mirikizumab
eli lilly
['lucent-1', 'ibd', 'mirikizumab']
up next, presents data from the lucent-1 induction trial, exploring speed of onset of symptom control with mirikizumab induction therapy in patients with moderately-to-severely active #ulcerativecolitis #uegweek #ibd #gitwitter 
The Lancet Gastroenterology & Hepatology publishes high-quality peer-reviewed research and reviews, comment, and news #gastroenterology #hepatology. IF=45.042